Arcturus Therapeutics Holdings (ARCT) Long-Term Investments (2018 - 2022)

Arcturus Therapeutics Holdings (ARCT) has 5 years of Long-Term Investments data on file, last reported at $131000.0 in Q1 2022.

• Quarterly Long-Term Investments fell 89.5% year-over-year to $131000.0 in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $131000.0 (down 89.5% YoY) and the FY2021 annual result came in at $515000.0, changed N/A from the prior year.
• Long-Term Investments declined to $131000.0 in Q1 2022, from $515000.0 in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $1.2 million in Q1 2021 to a low of $100000.0 in Q1 2020.
• A 5-year average of $493111.1 and a median of $303000.0 in 2019 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2021 — Long-Term Investments jumped 1148.0% — and 2022, when it plunged 89.5%.
• Tracing ARCT's Long-Term Investments over 5 years: stood at $288000.0 in 2018, then fell by 8.68% to $263000.0 in 2019, then slumped by 61.98% to $100000.0 in 2020, then soared by 415.0% to $515000.0 in 2021, then sank by 74.56% to $131000.0 in 2022.
• The last three Long-Term Investments figures came in at $131000.0 (Q1 2022), $515000.0 (Q4 2021), and $670000.0 (Q3 2021), per Business Quant data.